This content is machine translated Small cell lung carcinoma Regulatory extension for durvalumab Durvalumab was approved EU-wide in combination with chemotherapy of etoposide plus either cisplatin or carboplatin followed by durvalumab maintenance therapy for the first-line treatment of adults with advanced-stage small cell…
View Post 4 min This content is machine translated COVID-19 and chronic lung disease Up or down on meds? Is there an increased risk for COVID-19 patients if they have chronic lung disease? The answer to this is a resounding yes. Asthma patients are relatively well off compared to…
View Post 14 min This content is machine translated Palliative Care Respiratory distress in severe illness and at the end of life Respiratory distress triggers a very high level of suffering – both for those affected and for their relatives and professional environment. Respiratory distress is a common phenomenon and affects over…
View Post 15 min This content is machine translated Tuberculosis The new WHO recommendations for rapid diagnosis and treatment In 2018, approximately 10 million people contracted tuberculosis and 1.45 million died. An increasingly major challenge is the care of patients with multidrug-resistant tuberculosis (MDR-TB), for whom the two main…
View Post 5 min This content is machine translated Case study asthma Two diseases for the price of one A man presents to the pulmonary clinic with wheezing and shortness of breath. He has had asthma since childhood, which has so far been controlled with medication. The patient reports…
View Post 6 min This content is machine translated COPD therapy Biomarkers could facilitate many things 22-40% of all COPD patients experience at least one moderate or severe exacerbation annually. Patients with frequent exacerbations have a worse prognosis. A team of researchers has been looking at…
View Post 4 min This content is machine translated SARS-CoV-2 How does the corona pandemic affect disease management in COPD? The basic tenor of the expert statements is that COPD patients should continue their therapy to prevent exacerbations and thus also avoid the need for a visit to the doctor…
View Post 5 min This content is machine translated Chronic rhinosinusitis The right nose with biologics Rhinosinusitis is divided into two groups: chronic with nasal polyps (CRSwNP) and those without (CRSsNP). It is a common disease, affecting about 11% of the population throughout Europe. Therapeutic options…
View Post 3 min This content is machine translated Asthma Clean house – asthmatic child The prevalence of asthma in children has steadily increased in recent decades. Today, it is one of the leading causes of chronic disease at a young age. Some small studies…
View Post 4 min This content is machine translated COPD treatment Fewer exacerbations with mucolytics Mucolytics are included in several guidelines as a treatment option for patients with frequent exacerbations. According to GOLD, they can reduce exacerbations and marginally improve health status. However, evidence is…
View Post 4 min This content is machine translated Cystic fibrosis Even one mutated gene increases the risk In autosomal recessive diseases such as cystic fibrosis (CF), one is dealing with the inheritance of two mutated genes. Previously, CFTR* expression levels of 50% were thought to be sufficient…
